共 16 条
[1]
Pathogenesis of respiratory syncytial virus vaccineaugumented pathology. Graham BS. American Journal of Respiratory and Critical Care Medicine . 1995
[2]
Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotxic Tlymphocyte activity in mice challenged with respiratory syncytialvirus. Tang YW,Graham BS. The Journal of Clinical Investigation . 1994
[3]
Antigenic relationnessbetween glycoproteins of human respiratory syncytial virus subgroupsA and B: evaluation of the contribution of F and G glycoproteins toimmuity. Johnson PR,Olmsted RA,Prince GA,et al. Journal of Virology . 1987
[4]
Adjuvants influence thequantitative and quanlitative immune response in BALB/C mice immunized with respiratory syncytial virus ac Subunit vaccine. Neuzil KM,Johnson JE,Tang YW,et al. Vaccine . 1997
[5]
Interleukin-4 and interferon-γ: the quintessence of a mutual antagonistic relationship. Paludan SR. Scandinavian Journal of Immunology . 1998
[6]
Respiratory syncytial virusinfection in infant is associated with predominant Th-2 like response. Roman M,Calhoun WJ,Hinton DI,et al. American Journal of Respiratory and Critical Care Medicine . 1997
[7]
Protective epitopes on the futionof respiratory syncytial virus recognized by murine and bovine mono-clonal antibodies. Taylor G,Stott U,Furse J,et al. Journal of General Virology . 1992
[8]
Inerleukin-12 treatment during immuniza-tion elicits a T helper cell type l-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. Tang TW,Graham BS. J Inefect Dis . 1995